当前位置:首页 - 行情中心 - 东亚药业(605177) - 财务分析 - 现金流量表

东亚药业

(605177)

  

流通市值:22.48亿  总市值:22.69亿
流通股本:1.14亿   总股本:1.15亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金445,104,712.09346,215,522.64176,413,185.57653,293,092.1
  收到的税费返还10,886,076.025,535,894.65,535,894.656,074,573.63
  收到其他与经营活动有关的现金10,636,076.178,503,341.144,550,388.5341,907,041.54
  经营活动现金流入小计466,626,864.28360,254,758.38186,499,468.7751,274,707.27
  购买商品、接受劳务支付的现金158,341,844.33126,736,366.8354,331,715.82723,297,732.96
  支付给职工以及为职工支付的现金150,973,738.04105,993,429.6957,659,661.14201,028,541.02
  支付的各项税费55,723,559.9852,298,122.3831,723,796.8232,700,571.64
  支付其他与经营活动有关的现金37,909,338.0323,412,846.3210,650,356.7463,103,857.61
  经营活动现金流出小计402,948,480.38308,440,765.22154,365,530.521,020,130,703.23
  经营活动产生的现金流量净额63,678,383.951,813,993.1632,133,938.18-268,855,995.96
二、投资活动产生的现金流量:
  收回投资收到的现金597,400,166.67347,400,166.67130,000,000861,082,507.23
  取得投资收益收到的现金4,347,995.093,291,309.16524,137.153,320,236.55
  处置固定资产、无形资产和其他长期资产收回的现金净额5,311,885.725,123,374.641,117,509.421,438,491.4
  投资活动现金流入小计607,060,047.48355,814,850.47131,641,646.57865,841,235.18
  购建固定资产、无形资产和其他长期资产支付的现金20,428,411.0516,265,028.756,983,543.9674,256,035.04
  投资支付的现金558,450,000288,450,00073,000,000927,900,000
  投资活动现金流出小计578,878,411.05304,715,028.7579,983,543.961,002,156,035.04
  投资活动产生的现金流量净额28,181,636.4351,099,821.7251,658,102.61-136,314,799.86
三、筹资活动产生的现金流量:
  取得借款收到的现金50,200,00041,700,00019,800,000358,980,000
  收到其他与筹资活动有关的现金33,364,257.64--69,668,239.59
  筹资活动现金流入小计83,564,257.6441,700,00019,800,000428,648,239.59
  偿还债务支付的现金158,500,000128,500,00039,800,000155,780,000
  分配股利、利润或偿付利息支付的现金10,193,814.543,469,448.941,812,815.38,614,092.5
  支付其他与筹资活动有关的现金47,128,972.06791,566.7258,428.34104,571,864.09
  筹资活动现金流出小计215,822,786.6132,761,015.6641,671,243.64268,965,956.59
  筹资活动产生的现金流量净额-132,258,528.96-91,061,015.66-21,871,243.64159,682,283
四、汇率变动对现金及现金等价物的影响-1,144,184.43-790,630.77-347,708.981,128,906.78
五、现金及现金等价物净增加额-41,542,693.0611,062,168.4561,573,088.17-244,359,606.04
  加:期初现金及现金等价物余额243,966,360.23243,966,360.23243,966,360.23488,325,966.27
  期末现金及现金等价物余额202,423,667.17255,028,528.68305,539,448.4243,966,360.23
补充资料:
  净利润--118,376,942.74--82,432,149.13
  资产减值准备-71,298,798.49-44,115,906.92
  固定资产和投资性房地产折旧-89,630,245.23-149,003,507.72
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-89,630,245.23-149,003,507.72
  无形资产摊销-2,033,752.25-2,590,094.89
  长期待摊费用摊销-2,730,306.56-4,431,084.95
  处置固定资产、无形资产和其他长期资产的损失--89,140.38-387,524.12
  固定资产报废损失-2,015,779.97-2,798,211.15
  财务费用-19,007,250.43-16,695,785.23
  投资损失--2,166,952--2,934,751.91
  递延所得税--14,121,065.68--18,080,952.41
  其中:递延所得税资产减少--14,121,065.68--17,916,125.36
    递延所得税负债增加----164,827.05
  存货的减少-51,368,081.42-133,270,572.33
  经营性应收项目的减少--48,326,427.91--174,455,845.41
  经营性应付项目的增加--7,530,437.98--361,361,504.17
  其他-6,226,194.93-13,541,572.52
  不涉及现金收支的投资和筹资活动金额其他项目-1,344,356.88--
  现金的期末余额-255,028,528.68-243,966,360.23
  减:现金的期初余额-243,966,360.23-488,325,966.27
  现金及现金等价物的净增加额-11,062,168.45--244,359,606.04
公告日期2026-10-312026-08-312026-04-302026-04-23
审计意见(境内)标准无保留意见
TOP↑